These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29469783)

  • 1. Delayed presentation of toxic epidermal necrolysis-like cutaneous acute graft-versus-host disease in the setting of recent immunosuppressant discontinuation.
    Goyal PKK; Xu S; Choi J
    Dermatol Online J; 2017 Oct; 23(10):. PubMed ID: 29469783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxic epidermal necrolysis-like acute graft-versus-host disease in pediatric bone marrow transplant patients: Case series and review of the literature.
    Sheu Song J; Huang JT; Fraile Alonso MDC; Antaya RJ; Price HN; Funk T; Francois RA; Shah SD
    Pediatr Dermatol; 2022 Nov; 39(6):889-895. PubMed ID: 35730149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive toxic epidermal necrolysis versus acute graft versus host disease after allogenic hematopoietic stem-cell transplantation: challenges in diagnosis and management.
    Macedo FI; Faris J; Lum LG; Gabali A; Uberti JP; Ratanatharathorn V; White MT
    J Burn Care Res; 2014; 35(6):e431-5. PubMed ID: 24476990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic epidermal necrolysis versus cutaneous Graft-Versus-Host Disease in a hematopoietic stem cell transplant recipient: the role of elafin.
    Chen A; Chao K; Rodriguez L; Munday W; Worswick S
    Leuk Lymphoma; 2018 Sep; 59(9):2261-2263. PubMed ID: 29322835
    [No Abstract]   [Full Text] [Related]  

  • 5. Graft-versus-host disease or toxic epidermal necrolysis: diagnostic dilemma after liver transplantation.
    Jeanmonod P; Hubbuch M; Grünhage F; Meiser A; Rass K; Schilling MK; Kollmar O
    Transpl Infect Dis; 2012 Aug; 14(4):422-6. PubMed ID: 22650490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: two case reports.
    Milgrom SA; Nieto Y; Pinnix CC; Smith GL; Wogan CF; Rondon G; Medeiros LJ; Kebriaei P; Dabaja BS
    J Med Case Rep; 2016 Jul; 10():209. PubMed ID: 27465468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic Epidermal Necrolysis vs. Acute Cutaneous Graft Versus Host Disease after Hematopoietic Stem Cell Transplantation: A Diagnostic and Therapeutic Challenge.
    Rodríguez Tejero A; Badiola González J; Roldán Mateo L; Molina Leyva A
    Actas Dermosifiliogr (Engl Ed); 2021 Jan; 112(1):81-82. PubMed ID: 32986973
    [No Abstract]   [Full Text] [Related]  

  • 8. CD8+ lymphocytes in the blister fluid of severe acute cutaneous graft-versus-host disease: further similarities with toxic epidermal necrolysis.
    Correia O; Delgado L; Barbosa IL; Domingues JC; Azevedo R; Vaz CP; Pimentel P
    Dermatology; 2001; 203(3):212-6. PubMed ID: 11701973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease.
    Olson KA; West K; McCarthy PL
    Pharmacotherapy; 2014 Jun; 34(6):e60-4. PubMed ID: 24700567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of acute cutaneous graft-versus-host disease mimicking psoriasis vulgaris.
    Matsushita T; Hasegawa M; Shirasaki F; Fujimoto M; Yamazaki H; Sato S; Takehara K
    Dermatology; 2008; 216(1):64-7. PubMed ID: 18032902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic aspergillosis in a patient with non-Hodgkin's lymphoma developing acute graft-versus-host disease after autologous peripheral blood stem cell transplantation.
    Messina G; Quartarone E; Console G; Cuzzola M; Iacopino O; Martino M; Irrera G; Morabito F; Iacopino P
    Haematologica; 2002 Jul; 87(7):ECR22. PubMed ID: 12091138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
    Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
    Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cutaneous manifestations of graft-versus-host disease].
    Karrer S; Holler E; Szeimies RM
    Med Klin (Munich); 2001 Aug; 96(8):457-66. PubMed ID: 11560046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study comparing histological and immunophenotypic patterns in stage 4 skin graft vs host disease from toxic epidermal necrolysis.
    Naik H; Lockwood S; Saavedra A
    J Cutan Pathol; 2017 Oct; 44(10):857-860. PubMed ID: 28626936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical markers for histopathological diagnosis and differentiation of acute cutaneous graft-versus-host disease.
    Wegner J; Weidenthaler-Barth B; Engelbert J; Knothe M; Braun C; Helbig D; Sacher C; Kreft A; Wagner EM; Ziemer M; Meyer RG; von Stebut E
    Exp Dermatol; 2021 Dec; 30(12):1814-1819. PubMed ID: 34223669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous graft versus host disease occurring in a patient with multiple myeloma after autologous stem cell transplant.
    Fidler C; Klumpp T; Mangan K; Martin M; Sharma M; Emmons R; Lu M; Kropf P
    Am J Hematol; 2012 Feb; 87(2):219-21. PubMed ID: 22189875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric Cutaneous Graft Versus Host Disease: A Review.
    Shi CR; Huang JT; Nambudiri VE
    Curr Pediatr Rev; 2017; 13(2):100-110. PubMed ID: 28641548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic epidermal necrolysis possibly linked to hyperacute graft-versus-host disease after allogeneic bone marrow transplantation.
    Takeda H; Mitsuhashi Y; Kondo S; Kato Y; Tajima K
    J Dermatol; 1997 Oct; 24(10):635-41. PubMed ID: 9375462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
    Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.